HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydrochlorothiazide W/ Reserpine And Hydralazine, and when can generic versions of Hydrochlorothiazide W/ Reserpine And Hydralazine launch?
Hydrochlorothiazide W/ Reserpine And Hydralazine is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE?
- What are the global sales for HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE?
- What is Average Wholesale Price for HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE?
Summary for HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 1 |
| DailyMed Link: | HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE at DailyMed |
Recent Clinical Trials for HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| VA Office of Research and Development | |
| US Department of Veterans Affairs |
See all HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE clinical trials
US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE | hydralazine hydrochloride; hydrochlorothiazide; reserpine | TABLET;ORAL | 083770-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
